| Source Date | Board Meeting Date | Details |
|
05-Aug-2024
|
10-Aug-2024
|
Quarterly Results & the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2024. Further to intimation dated June 26, 2024, relating to Closure of Trading Window, the Trading Window for dealing in securities of the Company shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2024.
|
|
21-May-2024
|
27-May-2024
|
Final Dividend & Audited Results
|
|
01-Apr-2024
|
04-Apr-2024
|
Preferential Issue of shares & Inter alia, to consider and approve:- (1) proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights / qualified institutional placement or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
|
05-Feb-2024
|
13-Feb-2024
|
Quarterly Results
|
|
20-Dec-2023
|
26-Dec-2023
|
Preferential Issue of shares & Inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
|
02-Nov-2023
|
09-Nov-2023
|
Quarterly Results
|
|
07-Aug-2023
|
14-Aug-2023
|
Quarterly Results
|
|
26-Jun-2023
|
28-Jun-2023
|
Preferential Issue of shares & Issue Of Warrants Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a rights / preferential or any other permissible mode / and/or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
|
23-May-2023
|
30-May-2023
|
Final Dividend & Audited Results
|
|
06-Feb-2023
|
13-Feb-2023
|
Quarterly Results
|